VASA
Market Research - Cambridge, ENG, UK
VASA Details
Schistosomiasis is an infectious disease impacting around 1 billion people in 79 countries, mostly affecting poorer communities in Africa. 'Science' ranked a schistosomiasis-vaccine as one of the top-10 vaccines urgently needed, as chemotherapy is the currently preferred method for schistosomiasis control; but the effectiveness of mass-treatment programs is compromised by reinfection requiring regular re-treatment. An efficacious vaccine, with long-lasting protection against all schistosomiasis forms, would impact disease control. VASA is thus a clinical study to develop the continued efficacy of the SchistoShield®-vaccine in Burkina Faso and Madagascar. In baboon studies this SchistoShield® vaccine has been effective against all major schistosome species. It is the only vaccine candidate having consistently exhibited potent prophylactic, anti- fecundity, egg-induced pathology resolving, transmission-blocking and therapeutic efficacy. In addition to SchistoShield®, VASA aims to establish a multidisciplinary platform linking global research teams including those from Europe and disease-endemic countries, making best use of existing experience and propose state-of-the-art solutions to combat schistosomiasis. VASA Objectives:1) Assess the safety/immunogenicity of SchistoShield® in a Phase I clinical study in healthy adults from Africa;2) Refine and develop a female worm schistosome human challenge model3) To identify correlates of protection, innate and adaptive immune signatures, gene expression and the role of antibodies in the prevention/control of Schistosoma infections; 4) Foster a global consortium to advance research on schistosomiasis disease burden, vaccines and address downstream access constraints in resource-poor settingsProject Duration: June 2019 – May 2024 This Project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement (No.815643)
VASA Technologies
Captcha
reCAPTCHA
Load Balancers
Apache
CMS
WordPress.org
Hosted Forms
Gravity Forms
Fonts
Google Font API
Online Video Platforms
YouTube